- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Authors
Latest:
Navigating Compounded Semaglutide: What Health Care Providers Need to KnowThis article reviews the safety, efficacy, and regulatory concerns related to compounded semaglutide, with a focus on how health care providers can offer guidance and education to patients.
Latest:
Neulasta Onpro: A Coup de Grâce?With the rapid decline in average sales price of reference pegfilgrastim products due to biosimilar competition, health care institutions and payers may grapple with coverage of Neulasta Onpro.
Latest:
Experts Recount What Aspects of SECO Will Be Vital to Their Future PracticeAttendees and experts from the Southeastern Educational Congress of Optometry (SECO) 2025 meeting highlight research and sessions they will take away.
Latest:
FDA Fast Tracks BCMA-Targeted CAR T-Cell Therapy for R/R Multiple MyelomaThe FDA has granted a fast track designation to CB-011, a CRISPR-edited allogeneic CAR T-cell therapy developed by Caribou Biosciences, for the treatment of patients with relapsed/refractory multiple myeloma.
Latest:
The Relationship Between the Follow-up to Discharge Ratio and Length of StayThe objective was to evaluate the correlation between the follow-up to discharge ratio and average length of stay.
Latest:
Final Thoughts on Arrhythmia ManagementExperts agree that developing value-based care models for atrial fibrillation requires collaborative, data-driven strategies—leveraging clinical pharmacists for personalized medication management and prioritizing stroke prevention and rhythm control—while embracing innovation and workforce redesign to balance quality, cost-effectiveness, and avoid overdiagnosis in an evolving health care landscape.
Latest:
Factors Associated With Primary Care Physician Turnover in the VAThis longitudinal observational study found higher team satisfaction with workload to be significantly associated with lower primary care physician turnover.
Latest:
Addressing Social Determinants of Health Through Value-Based Oncology Care: Yale Podnos, MD, MPH, FACSYale Podnos, MD, MPH, FACS, discusses strategies to address social determinants of health in oncology, improve clinical trial enrollment for underserved communities, and leverage value-based care models to reduce financial toxicity and ensure equitable cancer care.
Latest:
Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF TransitionsSkilled nursing facilities (SNFs) with a high volume of referred patients with Alzheimer disease and related dementias may work harder to manage care transitions with less availability of resources that enable high-quality handoffs.
Latest:
Contributor: For Better or Worse, Inflation Isn’t New to Health InsurersIn this column, a health insurance executive discusses 2 ways to address rising inflation, including moving past the traditional fee-for-service payment model.
Latest:
Neoadjuvant KN026 Plus Docetaxel Demonstrate Early Activity in HER2+ Breast CancerA combination of KN026, a novel bispecific antibody, and docetaxel elicited responses with an acceptable toxicity profile when administered as neoadjuvant treatment in patients with HER2-positive (HER2+) early or locally advanced breast cancer.
Latest:
Pharmacist-Led Review of Empagliflozin and Ertugliflozin Following Formulary UpdateManagement of empagliflozin and ertugliflozin may be suboptimal following an insurance carrier’s formulary updates. Pharmacists may improve the management.
Latest:
Navigation and Clinician Payment Investments Enhance Colorectal Cancer Screening BenefitsInvesting in patient navigation and clinician incentives ensures colorectal cancer screening completion, improves early detection, reduces disparities, achieves cost savings, and advances population health for all stakeholders.
Latest:
Predicting Hospital Readmission in Medicaid Patients With Diabetes Using Administrative and Claims DataA statistical model based entirely on claims data can accurately predict 30-day hospital readmission in Medicaid patients with diabetes.
Latest:
Hospital Strategies in Commercial Episode-Based ReimbursementThis study reports qualitative findings from an explanatory sequential mixed-methods investigation to understand hospitals’ approaches to a novel commercial episode-based reimbursement incentive program.
Latest:
Effects of Individualized Nurse-Led Care Plans on Olaparib Treatment DurationA nurse-led personalized care program conducted through a specialty pharmacy prolonged medication persistence among patients with cancer receiving olaparib.
Latest:
The Role of Advanced Technologies in Improving Diabetes OutcomesThis article reviews underlying barriers to health care access and discusses how a value-based diabetes care model could improve patient outcomes and reduce long-term costs.
Latest:
Linking Insured Adults to Behavioral Health Care: A Cost-Saving SolutionConnecting primary care providers and commercially insured adults to outpatient behavioral health services via a digital platform improved health outcomes and reduced medical costs.
Latest:
COVID-19 Control in the United States: The Case for MaskingIn the control of COVID-19, the future perfect of the vaccine should not be the enemy of the present good, which is masking.
Latest:
In Vivo CAR T Takes Center Stage, With Results Shared for 4 MRD-Negative PatientsA groundbreaking in vivo CAR T-cell therapy shows promise for treating multiple myeloma, potentially revolutionizing cancer care with quicker, safer treatments.
Latest:
Identifying Complex Patients Using Adjusted Clinical Groups Risk Stratification ToolIn this study, the authors developed a method for use in primary care to identify a group of patients with complex care needs using Aggregated Diagnosis Groups.
Latest:
ASRS 2023: Intended vs Actual Treatment Intervals Between Intravitreal Anti-VEGF Injections: Effects of Treatment DaysIn the study, researchers found that nearly one-quarter of anti-VEGF injections were received at least 1 week later than intended.
Latest:
Health Outcomes of Dually Eligible Beneficiaries Under Different Medicare Payment ArrangementsWithin the same physician groups, 2-sided risk in Medicare Advantage (MA) was associated with higher quality and lower utilization for dually eligible beneficiaries compared with fee-for-service MA and traditional Medicare.
Latest:
A Case-Control Study of Length of Stay OutliersLength of stay outliers are associated with hospital-acquired infections, complications, and discharge to facility, as opposed to nonmodifiable risk factors like age and comorbidities.
Latest:
Social Determinants of Health Score: Does It Help Identify Those at Higher Cardiovascular Risk?Calculating a social score is feasible and it predicts cardiovascular outcomes. In order to do this, institutions have to collect social determinants of health.
Latest:
Factors Associated With Unplanned Admissions Among Patients With Chronic ConditionsThis study identified risk factors for unplanned admissions among patients with multiple chronic conditions to inform focused interventions.
